Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Ibrutinib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ibrutinibmarket, defines the market attractiveness level of Ibrutinib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ibrutinib industry, describes the types of Ibrutinib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ibrutinib market and the development prospects and opportunities of Ibrutinib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ibrutinib market in Chapter 13.
By Player:
Beacon Pharmaceuticals
Pharmacyclics Inc
Janssen Pharmaceuticals
Bluepharma
Johnson & Johnson
Incepta Pharmaceuticals
By Type:
90 Capsules/Box
120 Capsules/Box
By End-User:
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ibrutinib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ibrutinib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ibrutinib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ibrutinib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ibrutinib Market Analysis and Outlook to 2022
-
7.1 Global Ibrutinib Consumption (2017-2022)
-
7.2 United States Ibrutinib Consumption (2017-2022)
-
7.3 Europe Ibrutinib Consumption (2017-2022)
-
7.4 China Ibrutinib Consumption (2017-2022)
-
7.5 Japan Ibrutinib Consumption (2017-2022)
-
7.6 India Ibrutinib Consumption (2017-2022)
-
7.7 South Korea Ibrutinib Consumption (2017-2022)
8 Region and Country-wise Ibrutinib Market Analysis and Outlook to 2028
-
8.1 Global Ibrutinib Consumption Forecast (2022-2028)
-
8.2 United States Ibrutinib Consumption Forecast (2022-2028)
-
8.3 Europe Ibrutinib Consumption Forecast (2022-2028)
-
8.4 China Ibrutinib Consumption Forecast (2022-2028)
-
8.5 Japan Ibrutinib Consumption Forecast (2022-2028)
-
8.6 India Ibrutinib Consumption Forecast (2022-2028)
-
8.7 South Korea Ibrutinib Consumption Forecast (2022-2028)
9 Global Ibrutinib Market Outlook by Types and Applications to 2022
-
9.1 Global Ibrutinib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 90 Capsules/Box Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 120 Capsules/Box Consumption and Growth Rate (2017-2022)
-
9.2 Global Ibrutinib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Mantle Cell Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Chronic Lymphocytic Leukemia Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Small Lymphocytic Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Ibrutinib Market Outlook by Types and Applications to 2028
-
10.1 Global Ibrutinib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 90 Capsules/Box Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 120 Capsules/Box Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ibrutinib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Mantle Cell Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Chronic Lymphocytic Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Small Lymphocytic Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Ibrutinib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ibrutinib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ibrutinib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ibrutinib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ibrutinib Market Competitive Analysis
-
14.1 Beacon Pharmaceuticals
-
14.1.1 Beacon Pharmaceuticals Company Details
-
14.1.2 Beacon Pharmaceuticals Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Beacon Pharmaceuticals Ibrutinib Product and Service
-
14.2 Pharmacyclics Inc
-
14.2.1 Pharmacyclics Inc Company Details
-
14.2.2 Pharmacyclics Inc Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pharmacyclics Inc Ibrutinib Product and Service
-
14.3 Janssen Pharmaceuticals
-
14.3.1 Janssen Pharmaceuticals Company Details
-
14.3.2 Janssen Pharmaceuticals Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Janssen Pharmaceuticals Ibrutinib Product and Service
-
14.4 Bluepharma
-
14.4.1 Bluepharma Company Details
-
14.4.2 Bluepharma Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bluepharma Ibrutinib Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Ibrutinib Product and Service
-
14.6 Incepta Pharmaceuticals
-
14.6.1 Incepta Pharmaceuticals Company Details
-
14.6.2 Incepta Pharmaceuticals Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Incepta Pharmaceuticals Ibrutinib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ibrutinib
-
Figure Ibrutinib Picture
-
Table Global Ibrutinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ibrutinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ibrutinib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ibrutinib Consumption by Country (2017-2022)
-
Figure United States Ibrutinib Consumption and Growth Rate (2017-2022)
-
Table Europe Ibrutinib Consumption and Growth Rate (2017-2022)
-
Figure China Ibrutinib Consumption and Growth Rate (2017-2022)
-
Figure Japan Ibrutinib Consumption and Growth Rate (2017-2022)
-
Figure India Ibrutinib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ibrutinib Consumption and Growth Rate (2017-2022)
-
Figure Global Ibrutinib Consumption Forecast by Country (2022-2028)
-
Figure United States Ibrutinib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ibrutinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ibrutinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ibrutinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ibrutinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ibrutinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 90 Capsules/Box Consumption and Growth Rate (2017-2022)
-
Figure Global 120 Capsules/Box Consumption and Growth Rate (2017-2022)
-
Figure Global Mantle Cell Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Lymphocytic Leukemia Consumption and Growth Rate (2017-2022)
-
Figure Global Small Lymphocytic Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 90 Capsules/Box Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 120 Capsules/Box Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mantle Cell Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Lymphocytic Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small Lymphocytic Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ibrutinib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ibrutinib Export by Region (Top 5 Countries) (2017-2028)
-
Table Beacon Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Beacon Pharmaceuticals Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beacon Pharmaceuticals Ibrutinib Product and Service
-
Table Pharmacyclics Inc (Foundation Year, Company Profile and etc.)
-
Table Pharmacyclics Inc Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharmacyclics Inc Ibrutinib Product and Service
-
Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals Ibrutinib Product and Service
-
Table Bluepharma (Foundation Year, Company Profile and etc.)
-
Table Bluepharma Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bluepharma Ibrutinib Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Ibrutinib Product and Service
-
Table Incepta Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Incepta Pharmaceuticals Ibrutinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incepta Pharmaceuticals Ibrutinib Product and Service
-
